The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer
Oncotarget2017Vol. 8(24), pp. 38491–38500
Citations Over Time
Jun Zhang, Nan Wu, Tiemei Zhang, Tao Sun, Yi Su, Jing Zhao, Kun Mu, Jin Zhao, Ming Gao, Juntian Liu, Lin Gu
Abstract
FATS status is a biomarker in breast cancer to identify individuals likely to benefit from radiotherapy.
Related Papers
- → Dynamics of Breast Cancer under Different Rates of Chemoradiotherapy(2019)12 cited
- → The effects of radiotherapy for the treatment of contralateral breast cancer(2006)3 cited
- → Advanced radiotherapy techniques for breast cancer to minimize cardiovascular risk(2014)2 cited
- Interventional Combined Therapy for Advanced Cervical Cancer(2007)
- → Radiotherapy reaction and cosmetic result after breast conserving surgery for breast cancer(2013)